blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3541953

EP3541953 - METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS [Right-click to bookmark this link]
Former [2019/39]METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION
[2024/16]
StatusGrant of patent is intended
Status updated on  03.04.2024
Database last updated on 31.08.2024
FormerExamination is in progress
Status updated on  11.12.2020
FormerRequest for examination was made
Status updated on  23.08.2019
FormerThe international publication has been made
Status updated on  25.05.2018
Most recent event   Tooltip03.04.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Quest Diagnostics Investments LLC
500 Plaza Drive
Secaucus, NJ 07094 / US
[2019/39]
Inventor(s)01 / SANDERS, Heather
33608 Ortega Highway
San Juan Capistrano, California 92675 / US
02 / CLARKE, Nigel J.
2029 Rancho Corte
Vista, California 92084 / US
 [2019/39]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/39]
Application number, filing date17872827.513.11.2017
[2019/39]
WO2017US61311
Priority number, dateUS201662422338P15.11.2016         Original published format: US 201662422338 P
[2019/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018093723
Date:24.05.2018
Language:EN
[2018/21]
Type: A1 Application with search report 
No.:EP3541953
Date:25.09.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 24.05.2018 takes the place of the publication of the European patent application.
[2019/39]
Search report(s)International search report - published on:US24.05.2018
(Supplementary) European search report - dispatched on:EP01.04.2020
ClassificationIPC:C12Q1/6806, C12Q1/6883
[2024/16]
CPC:
C12Q1/6883 (EP,US); A61P43/00 (EP); C12Q1/6806 (EP,US);
C12Q1/6827 (US); C12Q2600/112 (US); C12Q2600/156 (EP,US);
C12Q2600/158 (US); C12Q2600/16 (US) (-)
C-Set:
C12Q1/6806, C12Q2531/113, C12Q2535/122 (EP,US)
Former IPC [2020/18]C12Q1/68, G01N33/49, G01N33/53
Former IPC [2019/39]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/39]
TitleGerman:VERFAHREN ZUM NACHWEIS VON MUTATIONEN VON ZYSTISCHER FIBROSE[2024/16]
English:METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS[2024/16]
French:MÉTHODES DE DÉTECTION DE MUTATIONS DE FIBROSE KYSTIQUE[2024/16]
Former [2019/39]VERFAHREN ZUM NACHWEIS VON MUTATIONEN VON ZYSTISCHER FIBROSE UNTER VERWENDUNG VON MITRA-SPITZEN-EXTRAKTION
Former [2019/39]METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION
Former [2019/39]MÉTHODES DE DÉTECTION DE MUTATIONS DE FIBROSE KYSTIQUE À L'AIDE D'UNE EXTRACTION DE POINTE MITRA
Entry into regional phase12.06.2019National basic fee paid 
12.06.2019Search fee paid 
12.06.2019Designation fee(s) paid 
12.06.2019Examination fee paid 
Examination procedure12.06.2019Examination requested  [2019/39]
02.11.2020Amendment by applicant (claims and/or description)
10.12.2020Despatch of a communication from the examining division (Time limit: M04)
20.04.2021Reply to a communication from the examining division
15.06.2021Despatch of a communication from the examining division (Time limit: M04)
12.10.2021Reply to a communication from the examining division
03.03.2023Despatch of a communication from the examining division (Time limit: M04)
13.07.2023Reply to a communication from the examining division
04.04.2024Communication of intention to grant the patent
Fees paidRenewal fee
14.11.2019Renewal fee patent year 03
13.11.2020Renewal fee patent year 04
19.10.2021Renewal fee patent year 05
13.10.2022Renewal fee patent year 06
29.09.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YA]US2016281166  (BHATTACHARJEE ARINDAM [US], et al) [Y] 1-13 * abstract * [A] 14,15;
 [YA]  - PHILIP DENNIFF ET AL, "Volumetric Absorptive Microsampling: A Dried Sample Collection Technique for Quantitative Bioanalysis", ANALYTICAL CHEMISTRY, US, (20140819), vol. 86, no. 16, doi:10.1021/ac5022562, ISSN 0003-2700, pages 8489 - 8495, XP055263361 [Y] 1-13 * abstract * [A] 14,15

DOI:   http://dx.doi.org/10.1021/ac5022562
 [YA]  - NEIL SPOONER ET AL, "A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit", BIOANALYSIS, London, UK, (20150401), vol. 7, no. 6, doi:10.4155/bio.14.310, ISSN 1757-6180, pages 653 - 659, XP055493432 [Y] 1-13 * abstract * [A] 14,15

DOI:   http://dx.doi.org/10.4155/bio.14.310
 [YA]  - ENDERLE YELIZ ET AL, "Clinical feasibility of dried blood spots: Analytics, validation, and applications", JOURNAL OF PHARMACEUTICAL AND BIOCHEMICAL ANALYSIS, ELSEVIER B.V, AMSTERDAM, NL, (20160623), vol. 130, doi:10.1016/J.JPBA.2016.06.026, ISSN 0731-7085, pages 231 - 243, XP029761144 [Y] 1-13 * abstract * [A] 14,15

DOI:   http://dx.doi.org/10.1016/j.jpba.2016.06.026
International search[Y]US2004009924  (STOVEN VERONIQUE [FR], et al) [Y] 29 * para [0020]-[0023]; [0047] -[0052]. *;
 [A]US2011082050  (HANTASH FERAS [US]) [A] 1* para [0028]; [0044]; [0054]; [0120]. *;
 [XY]US2016068906  (SJOGREN RICHARD [US], et al) [X] 1-3, 24, 25, 28 * para [0002]; [0019]; [0031]-[0050]; [0060]; [0160]-[0161]; [0188]. * [Y] 29
by applicantUS2016281166
    - DENNIFF et al., Analytical Chemistry, (20140000), vol. 86, no. 16, pages 8489 - 8495
    - SPOONER et al., Bioanalysis, (20150000), vol. 7, no. 6, pages 653 - 659
    - ENDERLE et al., Journal of Pharmaceutical and Biochemical analysis, (20160000), vol. 130, pages 231 - 243
    - PANNUS et al., Medicine, (20160000), vol. 95, no. 48, page e5475
    - BRANDAO et al., J. Clin. Virol., vol. 57, pages 98 - 102
    - SAWADOGO et al., J. Clin. Microbiol., (20140000), vol. 52, no. 11, pages 3878 - 83
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.